Stockscreener 앱 받기
0.5245
3.19%
-0.0173
Cosmos Health Inc 주식(COSM)의 최신 뉴스
Cosmos Health CEO Siokas acquires $220,000 in shares By Investing.com - Investing.com Australia
Cosmos Health CEO Siokas acquires $220,000 in shares - Investing.com
Zacks Small-Cap Research Initiates Coverage on Cosmos Health Inc. with $4.50 Valuation Per Share - Quiver Quantitative
AI research, crypto and $4.50 call put small-cap Cosmos Health on radar - Stock Titan
Cosmos Health CEO Siokas buys $57,000 in shares By Investing.com - Investing.com Nigeria
Cosmos Health CEO Siokas buys $57,000 in shares - Investing.com
Sunday’s Insider Activity: Big Buys at Zenas, Hycroft, and Major NVDA Sell - Investing.com Nigeria
Is Cosmos Health Inc. stock a defensive play in 2025July 2025 Trends & Accurate Intraday Trading Signals - Улправда
Cosmos Health Announces Launch Of Food Supplement Brand In Albania: Retail Sentiment Improves - MSN
Is Cosmos Health Inc. stock a safe haven assetStability vs Neutral Overview & support options for steady strides - Улправда
Cosmos Health Inc.Common Stock (NQ: COSM - FinancialContent
Insider Stock Purchases: January 09, 2026 - Quiver Quantitative
Cosmos Health CEO Siokas buys $81,000 in shares By Investing.com - Investing.com Canada
Cosmos Health CEO Siokas buys $81,000 in shares - Investing.com
Why Cosmos Health Inc. stock could see breakout soonPortfolio Profit Report & Consistent Profit Alerts - Улправда
Why Cosmos Health Inc. (V67A) stock could be next leaderDividend Hike & Verified Technical Signals - Улправда
How Cosmos Health Inc. stock reacts to Fed rate cutsEarnings Overview Report & Daily Price Action Insights - Улправда
How currency fluctuations impact Cosmos Health Inc. stockJuly 2025 Snapshot & Fast Moving Trade Plans - ulpravda.ru
Layoff Watch: What catalysts could drive Cosmos Health Inc stock higherWeekly Volume Report & Free Technical Pattern Based Buy Signals - Bộ Nội Vụ
Why Cosmos Health Inc. (V67A) stock trades below fair valueMarket Weekly Review & Technical Buy Zone Confirmation - ulpravda.ru
Why Cosmos Health Inc. stock could benefit from AI revolutionJobs Report & Expert Approved Momentum Ideas - Улправда
Cosmos Health CEO Siokas buys $65,000 in COSM stock By Investing.com - Investing.com South Africa
Cosmos Health CEO Siokas buys $65,000 in COSM stock - Investing.com
How Cosmos Health Inc. stock benefits from strong dollarJuly 2025 Closing Moves & Short-Term High Return Ideas - ulpravda.ru
Analysis Recap: How Cosmos Health Inc. stock reacts to Fed rate cuts2025 Institutional Moves & AI Driven Stock Movement Reports - Улправда
Insider Stock Purchases: January 07, 2026 - Quiver Quantitative
Cosmos Health CEO Siokas buys $72k in shares By Investing.com - Investing.com UK
Cosmos Health CEO Siokas buys $72k in shares - Investing.com
Cosmos Health to manufacture PathMuscle drug for Greek distributor By Investing.com - Investing.com Nigeria
Cosmos Health’s Wild Ride: Can COSM Survive Its Own Volatility? - AD HOC NEWS
Tangible book value per share of Cosmos Health Inc – MUN:V67A - TradingView — Track All Markets
Cosmos Health (COSM) Subsidiary to Manufacture PathMuscle for Li - GuruFocus
Cosmos Health stock rises on manufacturing deal with Libytec By Investing.com - Investing.com Nigeria
Cosmos Health stock rises on manufacturing deal with Libytec - Investing.com
Cosmos Health Inc. Subsidiary Cana Laboratories Enters Manufacturing Agreement for PathMuscle with Libytec Pharmaceutical in Greece - Quiver Quantitative
Cosmos Health to manufacture PathMuscle drug for Greek distributor - Investing.com
Cosmos Health Enters Manufacturing Agreement with Libytec - GlobeNewswire
About Us - FinancialContent
Cosmos Health Enters Manufacturing Agreement with Libytec for PathMuscle Medicine, with Five-Year Volumes Expected to Exceed 1.2 Million Units - Sahm
1.10%
0.28%
자본화:
|
볼륨(24시간):